Tikagrelor (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tikagrelor" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

5doi.org

2^nd place

3nih.gov

4^th place

3^rd place

3web.archive.org

1^st place

2wikipedia.org

low place

2europa.eu

68^th place

64^th place

1sciencedirect.com

149^th place

32^nd place

1wiley.com

222^nd place

57^th place

1archive-it.org

910^th place

1,138^th place

1fda.gov

447^th place

642^nd place

1nejm.org

2,374^th place

547^th place

archive-it.org

wayback.archive-it.org

„FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes”. FDA. 20. 7. 2011.. Arhivirano iz originala na datum 2017-01-12. Pristupljeno 2014-04-05.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Wallentin, Lars; Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Held, C; Horrow, J; Husted, S i dr.. (2009-08-30). „Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes”. NEJM 361 (11): 1045–57. DOI:10.1056/NEJMoa0904327. PMID 19717846. Arhivirano iz originala na datum 2010-01-04. Pristupljeno 2014-04-05.

europa.eu

ema.europa.eu

„Assessment Report for Brilique”. European Medicines Agency. January 2011. Arhivirano iz originala na datum 2018-05-17. Pristupljeno 2014-04-05.
„European Public Assessment Report Possia”. Arhivirano iz originala na datum 2018-06-12. Pristupljeno 2014-04-05.

fda.gov

„FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes”. FDA. 20. 7. 2011.. Arhivirano iz originala na datum 2017-01-12. Pristupljeno 2014-04-05.

nejm.org

content.nejm.org

Wallentin, Lars; Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Held, C; Horrow, J; Husted, S i dr.. (2009-08-30). „Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes”. NEJM 361 (11): 1045–57. DOI:10.1056/NEJMoa0904327. PMID 19717846. Arhivirano iz originala na datum 2010-01-04. Pristupljeno 2014-04-05.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Wallentin, Lars; Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Held, C; Horrow, J; Husted, S i dr.. (2009-08-30). „Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes”. NEJM 361 (11): 1045–57. DOI:10.1056/NEJMoa0904327. PMID 19717846. Arhivirano iz originala na datum 2010-01-04. Pristupljeno 2014-04-05.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

web.archive.org

„Assessment Report for Brilique”. European Medicines Agency. January 2011. Arhivirano iz originala na datum 2018-05-17. Pristupljeno 2014-04-05.
„European Public Assessment Report Possia”. Arhivirano iz originala na datum 2018-06-12. Pristupljeno 2014-04-05.
Wallentin, Lars; Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Held, C; Horrow, J; Husted, S i dr.. (2009-08-30). „Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes”. NEJM 361 (11): 1045–57. DOI:10.1056/NEJMoa0904327. PMID 19717846. Arhivirano iz originala na datum 2010-01-04. Pristupljeno 2014-04-05.

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

wiley.com

onlinelibrary.wiley.com

Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.